Andrew Yan - Atai Life Independent Director

ATAI
 Stock
  

USD 3.39  0.14  4.31%   

  Director
Mr. Andrew Y. Yan is Independent Director of ATA Inc. He is the founding managing partner of SAIF Partners IV, III and SB Asia Investment Fund II L.P., and president and executive managing director of Softbank Asia Infrastructure Fund. Before joining Softbank Asia Infrastructure Fund in 2001, Mr. Yan was a managing director and the head of the Hong Kong office of Emerging Markets Partnership from 1994 to 2001. From 1989 to 1994, he worked in the World Bank, the Hudson Institute and US Sprint Co. as an economist, research fellow and director for Asia, respectively, in Washington, DC. From 1982 to 1984, he was the chief engineer at the Jianghuai Airplane Corporationration Mr. Yan was a recipient of Chinas National Thousand Talents Program in 2012 and a member of its Selection Committee. He is a founding director of China Venture and Private Equity Association and a director of Peking University Endowment Investment Committee. He was also selected as one of the Fifty Finest Private Equity Investors in the World by the Private Equity International in 2007 No. 1 VCist of the Year by Forbes in 2008 and 2009. He was named the VC Professional of the Year by Asia VC Journal in 2009. He is currently an independent nonexecutive director of China Petroleum Chemical Corporationrationration, Mengniu Dairy Company Limited, China Resources Land Limited and Fosun International Limited and a nonexecutive director of Guodian Technology Environment Group Corporationrationration Limited, Digital China Holdings Limited, MOBI Development Co., Ltd., eSun Holdings Limited and China Huiyuan Juice Group Limited
Age: 59        
49 89 2153 9035  https://www.atai.life
Yan received a master’s degree from Princeton University as well as a bachelor’s degree in engineering from the Nanjing Aeronautic Institute in the PRC.

Atai Life Management Efficiency

Atai Life Sciences has return on total asset (ROA) of (37.52) % which means that it has lost $37.52 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (91.01) %, meaning that it created substantial loss on money invested by shareholders. Atai Life management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 725 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Atai Life Sciences has a current ratio of 15.47, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Atai Life until it has trouble settling it off, either with new capital or with free cash flow. So, Atai Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atai Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atai Life to invest in growth at high rates of return. When we think about Atai Life's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

Kazufumi HattoriDentsu Inc
2016
Philip LengyelSteel Connect
2014
Jacob BerningInsignia Systems
2018
Jeffrey WaldSteel Connect
2012
Marie LallemanCriteo SA ADR
2019
Patrick TerrellInuvo Inc
2013
Dominique VidalCriteo SA ADR
2013
Kent BurnettInuvo Inc
2016
Tao ZouXunlei Limited
2016
Frank ConnerInuvo Inc
2014
Edward CorcoranInsignia Systems
2015
Kiyoshi NakamuraDentsu Inc
2013
Kentaro KogaDentsu Inc
2016
Wataru MochizukiDentsu Inc
2018
Jenny WuXunlei Limited
2014
Donovan NealeMayTravelzoo
1999
Yoshio TakadaDentsu Inc
2018
Philip CooleyInsignia Systems
2015
Akira TonouchiDentsu Inc
2016
Suzanne ClarridgeInsignia Systems
2018
Nicholas SwensonInsignia Systems
2014
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. Atai Life Sciences (ATAI) is traded on NASDAQ Exchange in USA and employs 87 people.

Atai Life Sciences Leadership Team

Elected by the shareholders, the Atai Life's board of directors comprises two types of representatives: Atai Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atai Life. The board's role is to monitor Atai Life's management team and ensure that shareholders' interests are well served. Atai Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atai Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiaofeng Ma, Co-Founder, Chairman, CEO and Chairman of Nominations Committee
Yiu Tsui, Independent Director
Andrew Yan, Independent Director
ChengYaw Sun, CEO, Director
Jack Huang, President Director
Jun Zhang, President Director
Jianmin Ding, Sr. VP of Marketing and Bus. Devel.
Alex Tong, VP of Bus. Devel. and Investor Relations
Amy Tung, VP
Shuqiu Zhao, VP
Benson Tsang, Independent Consultant
Lin Wang, Co-Founder, Consultant and Director
Hope Ni, Independent Director

Atai Life Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Atai Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atai Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Pair Trading with Atai Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atai Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atai Life will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atai Life

+0.66JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
The ability to find closely correlated positions to Atai Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atai Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atai Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atai Life Sciences to buy it.
The correlation of Atai Life is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atai Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atai Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atai Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.